InsidersTradesSigma
Explore the complete record of transactions filed by Ibrahim Ramy, Director. Officer active across 2 companies, notably bluebird bio, Inc.. Cumulatively, 7 disclosures have been published. The latest transaction was disclosed on 8 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
7 of 7 declarations
Ramy Ibrahim is a Board Member at bluebird bio, Inc. and 2seventy bio, Inc. He provides valuable expertise to the board, contributing to the strategy and governance of these companies. His experience in the biopharmaceutical sector is an asset to bluebird bio and 2seventy bio.